CPC
BIIB icon

Congress Park Capital’s Biogen BIIB Stock Holding History

Congress Park Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,505
Closed -$486K – 111
2024
Q3 		$486K Sell
2,505
-278
-10% -$58.2K 0.18% 84
2024
Q2 		$645K Sell
2,783
-855
-24% -$186K 0.26% 70
2024
Q1 		$784K Sell
3,638
-479
-12% -$112K 0.35% 61
2023
Q4 		$1.07M Sell
4,117
-931
-18% -$229K 0.52% 47
2023
Q3 		$1.3M Buy
+5,048
New +$1.35M 0.68% 41
2022
Q2 		– Sell
-1,425
Closed -$300K – 131
2022
Q1 		$300K Sell
1,425
-325
-19% -$70.7K 0.15% 114
2021
Q4 		$420K Buy
1,750
+750
+75% +$193K 0.21% 90
2021
Q3 		$283K Buy
+1,000
New +$328K 0.14% 111
2021
Q1 		– Sell
-1,400
Closed -$343K – 128
2020
Q4 		$343K Buy
+1,400
New +$361K 0.2% 87
2019
Q2 		– Sell
-2,385
Closed -$564K – 92
2019
Q1 		$564K Sell
2,385
-1,155
-33% -$364K 0.49% 50
2018
Q4 		$1.06M Sell
3,540
-60
-2% -$19.1K 1.17% 27
2018
Q3 		$1.27M Sell
3,600
-10
-0.3% -$3.44K 1.14% 26
2018
Q2 		$1.05M Buy
3,610
+25
+0.7% +$7.03K 1.01% 30
2018
Q1 		$982K Sell
3,585
-300
-8% -$93.1K 1.01% 30
2017
Q4 		$1.24M Buy
+3,885
New +$1.25M 1.25% 27

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Congress Park Capital's BIIB Position: Q4 2024 in Review

Congress Park Capital sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,505 shares — an estimated $486K sold.

Congress Park Capital first reported a position in BIIB in Q4 2017 and held it in 15 quarters. The position peaked at $1.3M in Q3 2023. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Congress Park Capital reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Congress Park Capital sold 2,505 Biogen shares in Q4 2024, an estimated $486K.
  • Congress Park Capital first reported a position in Biogen in Q4 2017 and held it in 15 quarters.
  • Congress Park Capital's Biogen position peaked at $1.3M in Q3 2023.
  • 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Congress Park Capital's 13F filing for Q4 2024, filed 15 Jan 2025.